Pfizer Can't Halt Pay-For-Delay Suit Pending Appeal

Law360, Los Angeles (June 26, 2013, 5:59 PM EDT) -- A federal judge on Wednesday rejected Pfizer Inc.'s attempt to stay the state of West Virginia's allegations that it entered an anti-competitive settlement of a patent dispute with a generic-drug maker pending a petition to the Fourth Circuit to keep the case in federal court.

The decision comes more than a month after U.S. District Judge Robert C. Chambers remanded to a state court the West Virginia attorney general's antitrust suit against Pfizer and generics maker Ranbaxy Laboratories Ltd., which sought to make generic Lipitor. The...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

State of West Virginia v. Pfizer, Inc.


Case Number

3:13-cv-02546

Court

West Virginia Southern

Nature of Suit

Anti-Trust

Judge

Robert C. Chambers

Date Filed

February 12, 2013

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.